• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期膀胱癌(T2、T3和T4a期)的治疗。术前放疗与膀胱切除术对比根治性放疗及对残留肿瘤进行早期挽救性膀胱切除术的随机多中心研究。DAVECA方案8201。丹麦膀胱癌研究组。

Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group.

作者信息

Sell A, Jakobsen A, Nerstrøm B, Sørensen B L, Steven K, Barlebo H

出版信息

Scand J Urol Nephrol Suppl. 1991;138:193-201.

PMID:1785004
Abstract

From 1983 to 1986 183 patients with transitiocellular carcinoma of the urinary bladder, category T2-T4a, entered a randomized study. The patients were allocated to receive either preoperative irradiation (40 Gy) followed by cystectomy or radical irradiation (60 Gy) followed by salvage cystectomy in cases of residual tumor. The two randomization groups were comparable in regard to sex, age, T-categories, tumor size, histological grade and concomitant dysplasia. The two randomization groups included 88 and 95 patients respectively. The treatment plan was followed by 66 patients (75%) in the planned cystectomy group and by 88 (92%) in the radical radiotherapy group of which 27 (28%) were treated with salvage cystectomy. The results showed a trend to a higher survival rate following the combined treatment with preoperative irradiation and cystectomy compared to radical irradiation followed by salvage cystectomy in case of residual tumor, but a statistical significant difference could not be demonstrated. The lack of difference also applied according to the actually given treatment. There was no difference in surgical complications between planned and salvage cystectomy and there were no postoperative deaths among the cystectomized patients. The type of late complications was different in the two treatment groups, but there were no major differences in the number of complications except for the fact that all male patients experienced erective impotence after cystectomy. The T-category, response to radiotherapy and frequency of lymph node metastases were found to be of prognostic importance.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1983年至1986年,183例膀胱移行细胞癌患者(T2 - T4a期)进入一项随机研究。患者被分配接受术前放疗(40 Gy)后行膀胱切除术,或接受根治性放疗(60 Gy),若有残留肿瘤则行挽救性膀胱切除术。两个随机分组在性别、年龄、T分期、肿瘤大小、组织学分级和伴随发育异常方面具有可比性。两个随机分组分别包括88例和95例患者。计划膀胱切除术组有66例患者(75%)遵循了治疗方案,根治性放疗组有88例患者(92%)遵循了治疗方案,其中27例(28%)接受了挽救性膀胱切除术。结果显示,与残留肿瘤时接受根治性放疗后行挽救性膀胱切除术相比,术前放疗联合膀胱切除术的综合治疗后生存率有升高趋势,但未显示出统计学显著差异。根据实际给予的治疗情况,差异也不明显。计划膀胱切除术和挽救性膀胱切除术的手术并发症无差异,膀胱切除患者中无术后死亡病例。两个治疗组的晚期并发症类型不同,但并发症数量无主要差异,只是所有男性患者膀胱切除术后均出现勃起功能障碍。发现T分期、放疗反应和淋巴结转移频率具有预后重要性。(摘要截断于250字)

相似文献

1
Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group.晚期膀胱癌(T2、T3和T4a期)的治疗。术前放疗与膀胱切除术对比根治性放疗及对残留肿瘤进行早期挽救性膀胱切除术的随机多中心研究。DAVECA方案8201。丹麦膀胱癌研究组。
Scand J Urol Nephrol Suppl. 1991;138:193-201.
2
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.接受保守多模式治疗的局部晚期膀胱癌患者的临床结局
Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088.
3
Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.经尿道切除术、长期静脉输注化疗及超分割放疗对浸润性膀胱癌的保守治疗:长期结果
Cancer. 2004 Dec 1;101(11):2540-8. doi: 10.1002/cncr.20654.
4
[Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].膀胱浸润性移行细胞癌(I)。术前放疗(长期方案和短期方案)+根治性膀胱切除术与单纯根治性膀胱切除术治疗的两组比较。局部复发和转移分析
Actas Urol Esp. 1991 Mar-Apr;15(2):124-38.
5
Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201).
Scand J Urol Nephrol Suppl. 1989;125:115-20.
6
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
7
Chemotherapy, radical irradiation plus salvage cystectomy for bladder cancer--severe late small bowel morbidity.
Eur J Surg Oncol. 1993 Jun;19(3):279-82.
8
Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.
J Urol. 1997 Mar;157(3):805-7; discussion 807-8.
9
Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy.
Radiat Med. 1989 Mar-Apr;7(2):105-9.
10
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.根治性膀胱切除术与根治性膀胱切除术联合顺铂、长春碱和甲氨蝶呤化疗治疗肌层浸润性膀胱癌的随机试验。
J Urol. 1996 Feb;155(2):495-9; discussion 499-500.

引用本文的文献

1
A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice.多中心回顾性队列研究系列:日常实践中接受确定性同步放化疗的肌层浸润性膀胱癌患者
Eur Urol Open Sci. 2022 Mar 16;39:7-13. doi: 10.1016/j.euros.2022.02.010. eCollection 2022 May.
2
Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.肌层浸润性膀胱癌的膀胱保留治疗:全面综述。
Int Braz J Urol. 2020 Mar-Apr;46(2):169-184. doi: 10.1590/S1677-5538.IBJU.2020.99.01.
3
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.
国际泌尿外科学会-国际尿路上皮癌联盟咨询意见:膀胱癌治疗——肌层浸润性膀胱癌处理。
World J Urol. 2019 Jan;37(1):61-83. doi: 10.1007/s00345-018-2606-y. Epub 2019 Jan 25.
4
Current Concepts in the Management of Muscle Invasive Bladder Cancer.肌肉浸润性膀胱癌管理的当前概念
Indian J Surg Oncol. 2017 Mar;8(1):74-81. doi: 10.1007/s13193-016-0586-1. Epub 2016 Dec 15.
5
Contemporary management of muscle-invasive bladder cancer.肌层浸润性膀胱癌的当代治疗方法。
Expert Rev Anticancer Ther. 2012 Jul;12(7):941-50. doi: 10.1586/era.12.60.
6
Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.局部保留膀胱治疗局限性肌层浸润性膀胱癌:根治性放疗局部使用率对生存的影响。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e197-204. doi: 10.1016/j.ijrobp.2011.12.038. Epub 2012 Mar 6.
7
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.无法接受或拒绝膀胱切除术的浸润性膀胱癌患者的管理。
Ther Adv Urol. 2011 Jun;3(3):107-17. doi: 10.1177/1756287211407543.
8
Conservative treatment of invasive bladder cancer.浸润性膀胱癌的保守治疗。
Curr Oncol. 2009 Aug;16(4):36-47. doi: 10.3747/co.v16i4.411.
9
Effective bladder preservation strategy with low-dose radiation therapy and concurrent intraarterial chemotherapy for muscle-invasive bladder cancer.低剂量放射治疗联合同期动脉内化疗用于肌层浸润性膀胱癌的有效膀胱保留策略
Radiat Med. 2008 Apr;26(3):156-63. doi: 10.1007/s11604-007-0211-x.
10
Bladder-sparing approaches to invasive disease.针对浸润性疾病的膀胱保留方法。
World J Urol. 2006 Nov;24(5):517-29. doi: 10.1007/s00345-006-0114-y.